Nuveen Fund Advisors’s Edwards Lifesciences EW Stock Holding History

Nuveen Fund Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,255	Closed	-$363K	–	63
2018 Q3	$363K	Sell	6,255 -3,927	-39%	-$192K	0.81%	44
2018 Q2	$494K	Sell	10,182 -8,238	-45%	-$385K	0.61%	58
2018 Q1	$857K	Sell	18,420 -1,320	-7%	-$57.3K	0.39%	77
2017 Q4	$742K	Sell	19,740 -20,964	-52%	-$769K	0.22%	129
2017 Q3	$1.48M	Sell	40,704 -5,955	-13%	-$227K	0.3%	104
2017 Q2	$1.84M	Sell	46,659 -39,879	-46%	-$1.46M	0.29%	107
2017 Q1	$2.71M	Sell	86,538 -10,515	-11%	-$329K	0.36%	98
2016 Q4	$3.03M	Sell	97,053 -28,392	-23%	-$920K	0.44%	67
2016 Q3	$5.04M	Sell	125,445 -13,275	-10%	-$500K	0.7%	30
2016 Q2	$4.61M	Buy	+138,720	New	+$4.75M	0.71%	32

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Nuveen Fund Advisors's EW Position: Q4 2018 in Review

Nuveen Fund Advisors sold out of Edwards Lifesciences (EW) in Q4 2018, closing a stake of 6,255 shares — an estimated $363K sold.

Nuveen Fund Advisors first reported a position in EW in Q2 2016 and held it in 10 quarters. The position peaked at $5.04M in Q3 2016. 875 funds tracked by Wall St. Rank hold EW as of Q4 2018.

Nuveen Fund Advisors reported no remaining Edwards Lifesciences position as of Q4 2018 after selling out during the quarter.
Nuveen Fund Advisors sold 6,255 Edwards Lifesciences shares in Q4 2018, an estimated $363K.
Nuveen Fund Advisors first reported a position in Edwards Lifesciences in Q2 2016 and held it in 10 quarters.
Nuveen Fund Advisors's Edwards Lifesciences position peaked at $5.04M in Q3 2016.
875 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on Nuveen Fund Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.